B. Riley Financial initiated coverage on shares of Strata Critical Medical (NASDAQ:SRTA – Free Report) in a report issued on Wednesday, MarketBeat reports. The brokerage issued a buy rating and a $8.00 price objective on the stock.
Strata Critical Medical Stock Performance
NASDAQ SRTA opened at $4.38 on Wednesday. Strata Critical Medical has a 12-month low of $2.35 and a 12-month high of $6.02.
About Strata Critical Medical
Featured Articles
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
